Advantage Trust Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.46K Buy
+100
New +$8.06K ﹤0.01% 178
2025
Q4
Sell
-100
Closed -$8.24K 163
2025
Q3
$8.24K Hold
100
﹤0.01% 176
2025
Q2
$8.04K Buy
+100
New +$7.72K ﹤0.01% 190
2024
Q2
Sell
-605
Closed -$44.8K 176
2024
Q1
$44.8K Hold
605
0.03% 118
2023
Q4
$40K Buy
+605
New +$37.9K 0.03% 127

Other funds holding MET

Advantage Trust Company's MET Position: Q2 2026 in Review

Advantage Trust Company opened a new position in MetLife (MET) in Q2 2026: 100 shares worth $8.46K. The stake represents ﹤0.01% of the portfolio and ranks #178 among its holdings. This is a return to the name: Advantage Trust Company previously reported a position in MET as recently as Q3 2025.

Advantage Trust Company first reported a position in MET in Q4 2023 and has held it in 5 quarters since. The position peaked at $44.8K in Q1 2024. 1,447 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Advantage Trust Company held 100 shares of MetLife worth $8.46K as of Q2 2026.
  • MetLife was a new Advantage Trust Company position in Q2 2026.
  • MetLife made up ﹤0.01% of Advantage Trust Company's portfolio in Q2 2026, its #178 holding.
  • Advantage Trust Company first reported a position in MetLife in Q4 2023 and has held it in 5 quarters since.
  • Advantage Trust Company's MetLife position peaked at $44.8K in Q1 2024.
  • 1,447 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.